CORC

浏览/检索结果: 共16条,第1-10条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Evaluation of the combination mode and features of p38 MAPK inhibitors: construction of different pharmacophore models and molecular docking 期刊论文
MOLECULAR SIMULATION, 2019, 卷号: 45, 期号: 12, 页码: 975-984
作者:  Sun, Bin;  Zhang, Hong;  Dong, Yue;  Zhao, Liyu;  Han, Jun
收藏  |  浏览/下载:13/0  |  提交时间:2019/12/11
Recent Advance of Akt Inhibitors in Clinical Trials 期刊论文
CHEMISTRYSELECT, 2019, 卷号: 4, 期号: 31, 页码: 9040-9044
作者:  Guo, Kaiwen;  Tang, Wendi;  Zhuo, Huijun;  Zhao, Guisen
收藏  |  浏览/下载:9/0  |  提交时间:2019/12/11
JAK/STAT Signal Transduction: Promising Attractive Targets for Immune, Inflammatory and Hematopoietic Diseases 期刊论文
CURRENT DRUG TARGETS, 2018, 卷号: 19, 期号: 5, 页码: 487-500
作者:  Gao, Qianwen;  Liang, Xuewu;  Shaikh, Abdul Sami;  Zang, Jie;  Xu, Wenfang
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/11
Advances in studies of tyrosine kinase inhibitors and their acquired resistance 期刊论文
MOLECULAR CANCER, 2018, 卷号: 17
作者:  Jiao, Qinlian;  Bi, Lei;  Ren, Yidan;  Song, Shuliang;  Wang, Qin
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/11
Interactions between EGFR and PD-1/PD-L1 pathway: Implications for treatment of NSCLC 期刊论文
CANCER LETTERS, 2018, 卷号: 418, 页码: 1-9
作者:  Li, Xue;  Lian, Zhen;  Wang, Shuai;  Xing, Ligang;  Yu, Jinming
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/11
Microwave ablation combined with EGFR-TKIs versus only EGFR-TKIs in advanced NSCLC patients with EGFR-sensitive mutations 期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 34, 页码: 56714-56725
作者:  Wei, Zhigang;  Ye, Xin;  Yang, Xia;  Zheng, Aimin;  Huang, Guanghui
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/11
Current progress and outcomes of clinical trials on using epidermal growth factor receptor-tyrosine kinase inhibitor therapy in non-small cell lung cancer patients with brain metastases 期刊论文
慢性疾病与转化医学, 2017, 卷号: 3, 期号: 4, 页码: 221-229
作者:  Kong Lingling;  Wang Linlin;  Xing Ligang;  Yu Jinming
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/11
Clinical outcome of tyrosine kinase inhibitors alone or combined with radiotherapy for brain metastases from epidermal growth factor receptor (EGFR) mutant non small cell lung cancer (NSCLC) 期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 8, 页码: 13304-13311
作者:  Zhu, Qianqian;  Sun, Yanan;  Cui, Yingying;  Ye, Ke;  Yang, Chengliang
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/11
Insight to Pharmacokinetics of TKIs: Optimizing Practical Guidelines for Individualized Therapy 期刊论文
CURRENT DRUG METABOLISM, 2017, 卷号: 18, 期号: 3, 页码: 199-206
作者:  Wang, Ruiqing;  Zhong, Chaoqin;  Zhang, Chen;  Hua, Mingqiang;  Ma, Daoxin
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/12
Small activating ribonucleic acid reverses tyrosine kinase inhibitor resistance in epidermal growth factor receptor-mutant lung cancer by increasing the expression of phosphatase and tensin homolog 期刊论文
THORACIC CANCER, 2016, 卷号: 7, 期号: 4, 页码: 481-485
作者:  Li, Meng;  Peng, Zhongmin;  Ren, Wangang;  Wang, Zhou
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/16


©版权所有 ©2017 CSpace - Powered by CSpace